Smith & Nephew Acquires Healthpoint Biotherapeutics for $782M

London-based medical device company Smith & Nephew is buying Texas-based Healthpoint Biotherapeutics for $782 million, according to the Washington Post.

Advertisement

Healthpoint focuses on acute, chronic and burn-related wound care. The company hopes the acquisition will strengthen Smith & Nephew’s position in bioactive wound care.

Healthpoint and its 460 employees will continue to be based in Fort Worth.

More Articles on Devices:
Symmetry Surgical to Partner With Italian Device Maker Biocommerciale
Ulrich Releases Posterior Spine Stabilization Implant
Bioventus Leases $5M Office, Creates 44 Jobs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.